Brown: Risk Weighti...
Health Care: Drugs
Momenta Pharmaceuticals Inc. (MNTA: NASDAQ)
$13.03 -0.01 | -0.08%
05/17/13 - 04:00 PM ET
Insider Trading
| Historical Data | Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | 4 Mo. Ago | 5 Mo. Ago | 6 Mo. Ago |
|---|---|---|---|---|---|---|---|
| Net Insider Transaction | -31,440 | -40,732 | -10,292 | -10,292 | -21,675 | -22,275 | 69,761 |
| Shares Bought | 0 | 0 | 0 | 0 | 0 | 0 | 93,456 |
| Shares Sold | 31,440 | 40,732 | 10,292 | 10,292 | 21,675 | 22,275 | 23,695 |
Institutional Trading
| Historical Data | Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | 4 Mo. Ago | 5 Mo. Ago | 6 Mo. Ago |
|---|---|---|---|---|---|---|---|
| Total Shares Held | 43.35M | 49.07M | 44.39M | 45.05M | 49.49M | 46.88M | 42.54M |
| Shares Bought | 11.12M | 11.25M | 10.54M | 10.51M | 12.38M | 7.94M | 4.23M |
| Shares Sold | 7.29M | 7.26M | 8.63M | 8.62M | 4.28M | 3.90M | 3.75M |
Portfolios with MNTA
- Portfolio NameUser Type
- UserSm. Magic July 5 13
- ProDiscovery Capital Management
- ContributorTop-Rated Biotechnology Stocks
- Contributor8 Pharma Stocks to Watch
- Contributor10 Stocks With Highest Prof...
- ContributorRelative Strength Stocks 09...
- UserMF
- ContributorEarnings Short Squeeze Play...
- ContributorBreakout Stocks Of The Week...
- Contributor4 Drug Stocks Poised to Sta...
Latest MNTA Headlines from TheStreet
- Momenta Pharmaceuticals (MNTA) Shares Cross Above 200 DMA 05.13.13 | 04:05 pm
- Momenta Pharmaceuticals To Webcast Presentations At Two Upcoming Investor Conferences 05.09.13 | 04:05 pm
- 5 Names Seeing Bullish Options Flow 05.02.13 | 12:05 pm
- Oversold Conditions For Momenta Pharmaceuticals (MNTA) 04.30.13 | 12:04 pm
- Momenta Pharmaceuticals Reports First Quarter 2013 Financial Results 04.30.13 | 08:04 am
- Momenta Pharmaceuticals Breaks Above 200-Day Moving Average - Bullish For MNTA 04.22.13 | 12:04 pm
- Momenta Pharmaceuticals Announces Date Of First Quarter 2013 Financial Results Conference Call And Webcast 04.09.13 | 04:04 pm
- Momenta Pharmaceuticals To Webcast Presentations At Two Upcoming Investor Conferences 02.25.13 | 04:02 pm
- Momenta Pharmaceuticals Reports Fourth Quarter And Year End 2012 Financial Results 02.15.13 | 08:02 am
- Momenta Pharmaceuticals To Webcast Presentations At Two Upcoming Investor Conferences 02.07.13 | 09:02 am
Press Releases for MNTA
- Baxter And Momenta Announce Collaboration To Develop And Commercialize Follow-On Biologics - Business Wire 12.22.11 | 04:12 pm
Partner Headlines for MNTA
- Pluristem Therapeutics' Answer To Big Pharma's Question: What Do We Do Now? - Seeking Alpha 07.18.12 | 09:07 am
- Company News for June 26, 2012 - Corporate Summary - Zacks 06.26.12 | 10:06 am
- Cemex RISES 7% to Lead These 2 NYSE Top Percentage Winners - Wall St. Cheat Sheet 06.26.12 | 09:06 am
- Teva Jumps, But Still Must Repair Its Chart Further - Investor's Business Daily 06.25.12 | 05:06 pm
- Stocks Open In The Red: Teva Pharmaceuticals Surges - Investor's Business Daily 06.25.12 | 10:06 am
- Morning Market Losers - Benzinga 06.25.12 | 09:06 am
- Healthcare Biz Recap: FDA PROBES Pfizer's New Drug, Ventrus Biosciences ABANDONS Treatment - Wall St. Cheat Sheet 06.25.12 | 07:06 am
- Zynga GROWS in Social Gaming Market and 4 Fresh Analyst Insights - Wall St. Cheat Sheet 06.25.12 | 05:06 am
- Analyst Insights: Molycorp, AeroVironment, Teradyne, Pfizer, Momenta Pharma May 29th - Wall St. Cheat Sheet 05.29.12 | 10:05 am
- Notable Options Activity in Momenta Pharmaceuticals Inc - Benzinga 04.19.12 | 12:04 pm
